A controversial US-backed $1.6 million vaccine trial involving 14,000 newborns in West Africa has been cancelled

A controversial US-funded hepatitis B vaccine trial involving 14,000 newborns in Guinea-Bissau has been cancelled after the government refused to authorise the research, following international criticism over its proposed design and the risks it could pose to babies.

— Business Insider Africa
Read the full story on Business Insider Africa

This story was written and published by Business Insider Africa. Business.co.za shows its headline and teaser from the publisher’s RSS feed and links to the original.

What business people are saying

0

No comments yet. Be the first.

More in Business

All →